Article

Synthetically lethal interactions involving loss of the yeast ERG24: the sterol C-14 reductase gene.

Biology Department, Indiana University-Purdue University Indianapolis, 723 West Michigan Street, Indianapolis, IN 46202, USA.
Lipids (Impact Factor: 2.35). 03/2007; 42(1):69-76. DOI: 10.1007/s11745-006-1001-4
Source: PubMed

ABSTRACT ERG2 and ERG24 are yeast sterol biosynthetic genes which are targets of morpholine antifungal compounds. ERG2 and ERG24 encode the C-8 sterol isomerase and the C-14 reductase, respectively. ERG2 is regarded as a non-essential gene but the viability of ERG24 depends on genetic background, type of medium, and CaCl(2) concentration. We demonstrate that erg2 and erg24 mutants are viable in the deletion consortium background but are lethal when combined in the same haploid strain. The erg2erg24 double mutant can be suppressed by mutations in the sphingolipid gene ELO3 but not ELO2. Suppression occurs on rich medium but not on synthetic complete medium. We also demonstrate that the suppressed elo3erg2erg24 does not have a sterol composition markedly different from that of erg24. Further genetic analysis indicates that erg24 combined with mutations in erg6 or erg28 is synthetically lethal but when combined with mutations in erg3 is weakly viable. These results suggest that novel sterol intermediates probably contribute to the synthetic lethality observed in this investigation.

Download full-text

Full-text

Available from: M. Shah Alam Bhuiyan, Jan 06, 2014
0 Followers
 · 
102 Views
  • Source
    • "These pictures are representative of >85% of cells observed. Bar, 10 lm. in the BY genetic background grew on YPD medium similarly to its parental strain, which may be caused by differences in genetic background (Bhuiyan et al., 2007; Palermo et al., 1997). More importantly, erg24 mutant did not display resistance to valinomycin (data not shown). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Valinomycin and nigericin are potassium ionophores acting selectively on the mitochondrial inner membrane of Saccharomyces cerevisiae [Kovac, L., Bohmerova, E., Butko, P., 1982a. Ionophores and intact cells. I. Valinomycin and nigericin act preferentially on mitochondria and not on the plasma membrane of Saccharomyces cerevisiae. Biochim. Biophys. Acta 721, 341-348]. However, the molecular mechanism of their action is not understood. Here we show that their selective effect on mitochondrial membranes is not caused by the pleiotropic drug resistance system. To identify the molecular components mediating the action of ionophores we isolated several mutants specifically resistant to valinomycin and/or nigericin. In contrast to the parental strain, these mutants do not form respiratory-deficient cells in the presence of ionophores. Moreover, all mutants harbor extensively fragmented mitochondria and these morphological defects can be alleviated by the ionophores. Interestingly, we observed that these mitochondrial defects may be accompanied by changes in vacuolar dynamics. Our results demonstrate that the classical genetic approach can provide a starting point for the analysis of components involved in the action of ionophores on mitochondria-related processes in eukaryotic cell.
    Mitochondrion 04/2008; 8(2):117-29. DOI:10.1016/j.mito.2007.10.003 · 3.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Antifungal resistance at the gene level has been studied in Candida albicans for about a decade now. Cloning of C. albicans genes by homology to resistance genes in Saccharomyces cerevisiae, heterologous expression of C. albicans genes in S. cerevisiae, regulated expression in C. albicans, and microarray- based expression analysis, have allowed rapid progress in identifying and studying the fi ve major C. albicans genes involved in resistance to clinically used antifungals: ABC transporter genes CDR1 and CDR2, major facilitator effl ux gene MDR1, and ergosterol biosynthesis genes ERG11 and ERG3. Analysis of these genes indicates that resistance involves alterations to the enzyme targeted by fl uconazole (FLZ), encoded by ERG11, and upregulation of P-glycoprotein type ABC transporters and major facilitators (MFs) that effl ux azoles and terbinafi ne. Potential alterations to ERG3 or its regulation have been understudied in C. albicans. Resistant isolates from clinical samples, especially in oropharyngeal candidiasis (OPC), typically display stepwise mutations in more than one of these genes. Key mutations hyperactivate transcriptional activators of CDR1 or MDR1. However, it is clear from in vivo and in vitro studies that mutations of these major genes do not completely account for the evolution of high-level azole resistance in some clinical isolates. More work is needed to identify other genes that contribute to resistance in C. albicans. Very little is understood about reversible, adaptive resistance of C. albicans, despite its potential clinical signifi - cance. Most clinical failures to control non-OPC infections occur with in vitro susceptible strains. There has been important discovery of tolerance mechanisms to azoles. Heterologous studies in S. cerevisiae on regulation of target genes have been less useful because of differences in regulation in C. albicans. Nevertheless, recent progress has been made in identifying genes that regulate CDR1, MDR1, and ERG genes.
    12/2008: pages 347-407;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Between-pathway models (BPMs) are network motifs consisting of pairs of putative redundant pathways. In this article, we show how adding another source of high-throughput data--microarray gene expression data from knockout experiments--allows us to identify a compensatory functional relationship between genes from the two BPM pathways. We evaluate the quality of the BPMs from four different studies, and we describe how our methods might be extended to refine pathways.
    Journal of computational biology: a journal of computational molecular cell biology 03/2010; 17(3):477-87. DOI:10.1089/cmb.2009.0178 · 1.67 Impact Factor